Viewing Study NCT06111235


Ignite Creation Date: 2025-12-24 @ 10:13 PM
Ignite Modification Date: 2025-12-25 @ 7:48 PM
Study NCT ID: NCT06111235
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-09-09
First Post: 2023-10-25
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Study of Adjuvant Cretostimogene Grenadenorepvec for Treatment of Intermediate Risk NMIBC Following TURBT
Sponsor: CG Oncology, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module